0 Bedömningar
ID

14118

Beskrivning

Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management; ODM derived from: https://clinicaltrials.gov/show/NCT01908075

Länk

https://clinicaltrials.gov/show/NCT01908075

Nyckelord

Versioner (1)
  1. 2016-03-30 2016-03-30 -
Uppladdad den

30 mars 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Eligibility Asthma NCT01908075

    Engelsk

    Eligibility Asthma NCT01908075

    1 Formulär  
    1. StudyEvent: Eligibility
      1. Eligibility Asthma NCT01908075
    Inclusion Criteria
    Beskrivning

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    aged: 18-80 years 61-80 years to be non-smokers only
    Beskrivning

    Age | Non-smoker

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    UMLS CUI [2]
    C0337672
    evidence of asthma: a diagnostic code for asthma or two scripts for asthma..
    Beskrivning

    Asthma

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0004096
    baseline fp/sal therapy: ≥2 prescription for ics/laba therapy as fp/sal
    Beskrivning

    fluticasone | salmeterol | Therapeutic procedure | inhaled steroids | Adrenergic beta-2 Receptor Agonists | Therapeutic procedure

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0082607
    UMLS CUI [1,2]
    C0073992
    UMLS CUI [1,3]
    C0087111
    UMLS CUI [2,1]
    C2065041
    UMLS CUI [2,2]
    C2936789
    UMLS CUI [2,3]
    C0087111
    evidence of continuing therapy: include only patients who receive ≥2 prescriptions for the therapy under study during the outcome year (i.e. ≥1 prescription at the index date and ≥1 other). uk average is 3-4 prescriptions refilled per year, so ≥2 ensures capture of "real-life" data.
    Beskrivning

    Continuous therapeutic procedure | prescription

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0087111
    UMLS CUI [1,2]
    C0549178
    UMLS CUI [2]
    C1521941
    evidence of switching for economic reasons: fp/sal patients from practices with ≥5 switches to fostair in a 3 month period to minimise data taken from switching of anomalous patients; optimal practices for inclusion are those switching "wholesale" for economic reasons.
    Beskrivning

    Therapy change | fluticasone salmeterol

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C3665894
    UMLS CUI [2,1]
    C0082607
    UMLS CUI [2,2]
    C0073992
    UMLS CUI [2,3]
    C0087111
    Exclusion Criteria
    Beskrivning

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    any chronic respiratory disease other than asthma
    Beskrivning

    Chronic disease of respiratory system

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0264220
    UMLS CUI [2]
    C0004096
    are receiving maintenance oral steroid therapy during baseline period
    Beskrivning

    Oral steroid therapy

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0001617
    UMLS CUI [1,2]
    C0087111
    Tillbaka till toppen

    Similar models

    Eligibility Asthma NCT01908075

    1 Formulär
    1. StudyEvent: Eligibility
      1. Eligibility Asthma NCT01908075
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Age | Non-smoker
    Item
    aged: 18-80 years 61-80 years to be non-smokers only
    boolean
    C0001779 (UMLS CUI [1])
    C0337672 (UMLS CUI [2])
    Asthma
    Item
    evidence of asthma: a diagnostic code for asthma or two scripts for asthma..
    boolean
    C0004096 (UMLS CUI [1])
    fluticasone | salmeterol | Therapeutic procedure | inhaled steroids | Adrenergic beta-2 Receptor Agonists | Therapeutic procedure
    Item
    baseline fp/sal therapy: ≥2 prescription for ics/laba therapy as fp/sal
    boolean
    C0082607 (UMLS CUI [1,1])
    C0073992 (UMLS CUI [1,2])
    C0087111 (UMLS CUI [1,3])
    C2065041 (UMLS CUI [2,1])
    C2936789 (UMLS CUI [2,2])
    C0087111 (UMLS CUI [2,3])
    Continuous therapeutic procedure | prescription
    Item
    evidence of continuing therapy: include only patients who receive ≥2 prescriptions for the therapy under study during the outcome year (i.e. ≥1 prescription at the index date and ≥1 other). uk average is 3-4 prescriptions refilled per year, so ≥2 ensures capture of "real-life" data.
    boolean
    C0087111 (UMLS CUI [1,1])
    C0549178 (UMLS CUI [1,2])
    C1521941 (UMLS CUI [2])
    Therapy change | fluticasone salmeterol
    Item
    evidence of switching for economic reasons: fp/sal patients from practices with ≥5 switches to fostair in a 3 month period to minimise data taken from switching of anomalous patients; optimal practices for inclusion are those switching "wholesale" for economic reasons.
    boolean
    C3665894 (UMLS CUI [1])
    C0082607 (UMLS CUI [2,1])
    C0073992 (UMLS CUI [2,2])
    C0087111 (UMLS CUI [2,3])
    Item Group
    C0680251 (UMLS CUI)
    Chronic disease of respiratory system
    Item
    any chronic respiratory disease other than asthma
    boolean
    C0264220 (UMLS CUI [1])
    C0004096 (UMLS CUI [2])
    Oral steroid therapy
    Item
    are receiving maintenance oral steroid therapy during baseline period
    boolean
    C0001617 (UMLS CUI [1,1])
    C0087111 (UMLS CUI [1,2])
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial